Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Association analysis between HLA-A, -B, -C, -DRB1, and -DQB1 with nasopharyngeal carcinoma among a Han population in Northwestern China.

Wang R, Hu Y, Yindom LM, Huang L, Wu R, Wang D, Chang C, Rostron T, Dong T, Wang X.

Hum Immunol. 2014 Mar;75(3):197-202. doi: 10.1016/j.humimm.2013.12.015. Epub 2013 Dec 31.

PMID:
24389314
2.

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.

Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR.

Elife. 2013 Nov 5;2:e01202. doi: 10.7554/eLife.01202.

3.

HLA correlates in a cohort of slow progressors from China: effects on HIV-1 disease progression.

Rai MA, Zhang Y, Yindom LM, Holmes J, Yu LM, Hao C, Rostron T, Yan H, Zhang YL, Cai C, McMichael AJ, Dong T, Rowland-Jones SL, Blais ME, Xu KY.

AIDS. 2013 Nov 13;27(17):2822-4. doi: 10.1097/QAD.0000000000000011.

PMID:
23942057
4.

High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphism.

Blais ME, Zhang Y, Rostron T, Griffin H, Taylor S, Xu K, Yan H, Wu H, James I, John M, Dong T, Rowland-Jones SL.

J Immunol. 2012 May 1;188(9):4663-70. doi: 10.4049/jimmunol.1103472. Epub 2012 Apr 2.

5.

HLA class I and class II associations in dengue viral infections in a Sri Lankan population.

Malavige GN, Rostron T, Rohanachandra LT, Jayaratne SD, Fernando N, De Silva AD, Liyanage M, Ogg G.

PLoS One. 2011;6(6):e20581. doi: 10.1371/journal.pone.0020581. Epub 2011 Jun 9.

6.

Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China.

Dong T, Zhang Y, Xu KY, Yan H, James I, Peng Y, Blais ME, Gaudieri S, Chen X, Lun W, Wu H, Qu WY, Rostron T, Li N, Mao Y, Mallal S, Xu X, McMichael A, John M, Rowland-Jones SL.

Blood. 2011 Jul 7;118(1):98-106. doi: 10.1182/blood-2010-06-291963. Epub 2011 May 11.

7.

HLA analysis of Sri Lankan Sinhalese predicts North Indian origin.

Malavige GN, Rostron T, Seneviratne SL, Fernando S, Sivayogan S, Wijewickrama A, Ogg GS.

Int J Immunogenet. 2007 Oct;34(5):313-5.

PMID:
17845299
8.

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.

Dorrell L, Yang H, Ondondo B, Dong T, di Gleria K, Suttill A, Conlon C, Brown D, Williams P, Bowness P, Goonetilleke N, Rostron T, Rowland-Jones S, Hanke T, McMichael A.

J Virol. 2006 May;80(10):4705-16.

9.

nef gene sequence variation among HIV-1-infected African children.

Chakraborty R, Reinis M, Rostron T, Philpott S, Dong T, D'Agostino A, Musoke R, Silva E, Stumpf M, Weiser B, Burger H, Rowland-Jones SL.

HIV Med. 2006 Mar;7(2):75-84.

10.

Correlates of delayed disease progression in HIV-1-infected Kenyan children.

Chakraborty R, Morel AS, Sutton JK, Appay V, Ripley RM, Dong T, Rostron T, Ogola S, Palakudy T, Musoke R, D'Agostino A, Ritter M, Rowland-Jones SL.

J Immunol. 2005 Jun 15;174(12):8191-9.

11.

Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission.

Farquhar C, Rowland-Jones S, Mbori-Ngacha D, Redman M, Lohman B, Slyker J, Otieno P, Obimbo E, Rostron T, Ochieng J, Oyugi J, Bosire R, John-Stewart G.

AIDS Res Hum Retroviruses. 2004 Jul;20(7):692-7.

12.

Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations.

Fang G, Kuiken C, Weiser B, Rowland-Jones S, Plummer F, Chen CH, Kaul R, Anzala AO, Bwayo J, Kimani J, Philpott SM, Kitchen C, Sinsheimer JS, Gaschen B, Lang D, Shi B, Kemal KS, Rostron T, Brunner C, Beddows S, Sattenau Q, Paxinos E, Oyugi J, Burger H.

J Infect Dis. 2004 Aug 15;190(4):697-701. Epub 2004 Jul 13.

PMID:
15272396
13.

Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes.

Beattie T, Kaul R, Rostron T, Dong T, Easterbrook P, Jaoko W, Kimani J, Plummer F, McMichael A, Rowland-Jones S.

AIDS. 2004 Jul 23;18(11):1595-8.

PMID:
15238779
14.

Extraoral x-ray film continues to evolve, improve.

Rostron T.

Dent Assist. 2003 Sep-Oct;72(5):22-5. No abstract available.

PMID:
14596151
15.

Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors.

Papagno L, Appay V, Sutton J, Rostron T, Gillespie GM, Ogg GS, King A, Makadzanhge AT, Waters A, Balotta C, Vyakarnam A, Easterbrook PJ, Rowland-Jones SL.

Clin Exp Immunol. 2002 Dec;130(3):509-17.

16.

HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate.

Chakraborty R, Gillespie GM, Reinis M, Rostron T, Dong T, Philpott S, Burger H, Weiser B, Peto T, Rowland-Jones SL.

AIDS. 2002 Oct 18;16(15):2085-7.

PMID:
12370511
17.

HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades.

Bird TG, Kaul R, Rostron T, Kimani J, Embree J, Dunn PP, Bwayo JJ, Plummer FA, Rowland-Jones SL, Dong T; Oxford-Nairobi HLA Collaborative Group.

AIDS. 2002 Sep 27;16(14):1899-904.

PMID:
12351949
18.

Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission.

Polycarpou A, Ntais C, Korber BT, Elrich HA, Winchester R, Krogstad P, Wolinsky S, Rostron T, Rowland-Jones SL, Ammann AJ, Ioannidis JP; Ariel Project.

AIDS Res Hum Retroviruses. 2002 Jul 20;18(11):741-6.

PMID:
12167265
19.

Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.

Gillespie GM, Kaul R, Dong T, Yang HB, Rostron T, Bwayo JJ, Kiama P, Peto T, Plummer FA, McMichael AJ, Rowland-Jones SL.

AIDS. 2002 May 3;16(7):961-72.

PMID:
11953462
20.

New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers.

Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T, Kiama P, Rutherford J, Njagi E, Mwangi F, Rostron T, Onyango J, Oyugi J, MacDonald KS, Bwayo JJ, Plummer FA.

Immunol Lett. 2001 Nov 1;79(1-2):3-13.

PMID:
11595284
21.

Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.

Vyakarnam A, Eyeson J, Teo I, Zuckerman M, Babaahmady K, Schuitemaker H, Shaunak S, Rostron T, Rowland-Jones S, Simmons G, Clapham P.

AIDS. 2001 Sep 7;15(13):1613-26.

PMID:
11546935
22.

CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality.

John GC, Bird T, Overbaugh J, Nduati R, Mbori-Ngacha D, Rostron T, Dong T, Kostrikis L, Richardson B, Rowland-Jones SL.

J Infect Dis. 2001 Jul 1;184(1):89-92. Epub 2001 May 31.

23.

Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.

Dorrell L, Willcox BE, Jones EY, Gillespie G, Njai H, Sabally S, Jaye A, DeGleria K, Rostron T, Lepin E, McMichael A, Whittle H, Rowland-Jones S.

Eur J Immunol. 2001 Jun;31(6):1747-56.

24.

CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects.

Kaul R, Dong T, Plummer FA, Kimani J, Rostron T, Kiama P, Njagi E, Irungu E, Farah B, Oyugi J, Chakraborty R, MacDonald KS, Bwayo JJ, McMichael A, Rowland-Jones SL.

J Clin Invest. 2001 May;107(10):1303-10.

25.

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Kaul R, Rowland-Jones SL, Kimani J, Dong T, Yang HB, Kiama P, Rostron T, Njagi E, Bwayo JJ, MacDonald KS, McMichael AJ, Plummer FA.

J Clin Invest. 2001 Feb;107(3):341-9.

26.

CD8(+) T-cell selection, function, and death in the primary immune response in vivo.

Callan MF, Fazou C, Yang H, Rostron T, Poon K, Hatton C, McMichael AJ.

J Clin Invest. 2000 Nov;106(10):1251-61.

27.

Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.

Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.

Arthritis Res. 2000;2(2):154-64. Epub 2000 Feb 7.

28.

Maternal SDF1 3'A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission.

John GC, Rousseau C, Dong T, Rowland-Jones S, Nduati R, Mbori-Ngacha D, Rostron T, Kreiss JK, Richardson BA, Overbaugh J.

J Virol. 2000 Jun;74(12):5736-9.

29.

HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

Kaul R, Plummer FA, Kimani J, Dong T, Kiama P, Rostron T, Njagi E, MacDonald KS, Bwayo JJ, McMichael AJ, Rowland-Jones SL.

J Immunol. 2000 Feb 1;164(3):1602-11.

30.

Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.

Easterbrook PJ, Rostron T, Ives N, Troop M, Gazzard BG, Rowland-Jones SL.

J Infect Dis. 1999 Oct;180(4):1096-105.

PMID:
10479136
31.

Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome.

Tan R, Xu X, Ogg GS, Hansasuta P, Dong T, Rostron T, Luzzi G, Conlon CP, Screaton GR, McMichael AJ, Rowland-Jones S.

Blood. 1999 Mar 1;93(5):1506-10.

32.

Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa.

Dorrell L, Dong T, Ogg GS, Lister S, McAdam S, Rostron T, Conlon C, McMichael AJ, Rowland-Jones SL.

J Virol. 1999 Feb;73(2):1708-14.

33.

Prolonged CD8+ T-cell expansions after adoptive transfer of syngeneic lymphocytes between HIV-discordant identical twins.

Tan R, Wilson JD, Rostron T, Peto T, McMichael AJ, Rowland-Jones SL.

AIDS. 1998 Nov 12;12(16):2240-1. No abstract available.

PMID:
9833875
34.

CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research.

Anzala AO, Ball TB, Rostron T, O'Brien SJ, Plummer FA, Rowland-Jones SL.

Lancet. 1998 May 30;351(9116):1632-3. No abstract available.

PMID:
9620723
35.

Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades.

Bertoletti A, Cham F, McAdam S, Rostron T, Rowland-Jones S, Sabally S, Corrah T, Ariyoshi K, Whittle H.

J Virol. 1998 Mar;72(3):2439-48.

36.

Maternal viral load, CD4 cell count and vertical transmission of HIV-1.

O'Shea S, Newell ML, Dunn DT, Garcia-Rodriguez MC, Bates I, Mullen J, Rostron T, Corbett K, Aiyer S, Butler K, Smith R, Banatvala JE.

J Med Virol. 1998 Feb;54(2):113-7.

PMID:
9496369
37.

Significance of placental damage in vertical transmission of human immunodeficiency virus.

Burton GJ, O'Shea S, Rostron T, Mullen JE, Aiyer S, Skepper JN, Smith R, Banatvala JE.

J Med Virol. 1996 Nov;50(3):237-43.

PMID:
8923288
38.

Physical breaks in the placental trophoblastic surface: significance in vertical transmission of HIV.

Burton GJ, O'Shea S, Rostron T, Mullen JE, Aiyer S, Skepper JN, Smith R, Banatvala J.

AIDS. 1996 Sep;10(11):1294-6. No abstract available.

PMID:
8883596
39.

Stability of infectious HIV in clinical samples and isolation from small volumes of whole blood.

O'Shea S, Rostron T, Mullen JE, Banatvala JE.

J Clin Pathol. 1994 Feb;47(2):152-4.

40.

Quantitation of HIV: correlation with clinical, virological, and immunological status.

O'Shea S, Rostron T, Hamblin AS, Palmer SJ, Banatvala JE.

J Med Virol. 1991 Sep;35(1):65-9.

PMID:
1940886

Supplemental Content

Loading ...
Support Center